According to Sino Biopharmaceutical's latest financial reports the company's total liabilities are HK$28.00 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | HK$28.10 B | -5.03% |
2022-12-31 | HK$29.59 B | 5.99% |
2021-12-31 | HK$27.91 B | -5.25% |
2020-12-31 | HK$29.46 B | 55.9% |
2019-12-31 | HK$18.90 B | 47.51% |
2018-12-31 | HK$12.81 B | 28.16% |
2017-12-31 | HK$9.99 B | 16.16% |
2016-12-31 | HK$8.60 B | 42.17% |
2015-12-31 | HK$6.05 B | 13.04% |
2014-12-31 | HK$5.35 B | 94.9% |
2013-12-31 | HK$2.74 B | 43.2% |
2012-12-31 | HK$1.91 B | 33.9% |
2011-12-31 | HK$1.43 B | 8.27% |
2010-12-31 | HK$1.32 B | 79.31% |
2009-12-31 | HK$0.73 B | 20.07% |
2008-12-31 | HK$0.61 B | 69.64% |
2007-12-31 | HK$0.36 B | 97.51% |
2006-12-31 | HK$0.18 B | 11.15% |
2005-12-31 | HK$0.16 B | -41.72% |
2004-12-31 | HK$0.28 B | 18.19% |
2003-12-31 | HK$0.23 B | 39.76% |
2002-12-31 | HK$0.17 B | 86.78% |
2001-12-31 | HK$91.78 M |